once-weekly semaglutide in persons with obesity and knee osteoarthritis Another GLP-1 success, for relief of people obesity, a randomized trial @NEJM https://t.co/tabAHXy7Ow Once-Weekly Semaglutide in Persons with

These agents have a beneficial effect on pancreatic islet function by facilitating the secretion of insulin in response to ambient blood glucose levels and inhibiting glucagon secretion both directly and indirectly

Emerging evidence that stevia, monk fruit, and sugar alcohols may provide modest metabolic benefits compared to sugar [A: 1:03:00, V: 1:10:45]

Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging

That observation has implications for conversion accuracy: the precision difference between underdosing at 4.5mg versus hitting 5mg exactly may matter more at lower doses than the difference between 14mg and 15mg at higher doses

Understanding how well semaglutide works can help people with diabetes make informed decisions about their treatment

Patients were required to have a documented weight or BMI in the year before starting their intervention and to remain in active follow-up through 15 months post-intervention